BD’s Global Health Initiative recognizes that diagnostic tools and medical devices commonly used in the developed world do not always meet the unique healthcare demands of the developing world. To improve the delivery of healthcare in these resource-limited settings, BD invests in new technologies that help address site-appropriate healthcare challenges faced by the developing world.

An example of BD's efforts in this area includes the TB Core Team, comprised of BD associates from cross-business segments who are charged with finding new solutions to improve the diagnosis of active tuberculosis disease.

Learn More About...

• BD Biosciences Announces Availability of New CD4 Technology in Africa

 
• BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection Technology

 
• Research Shows CD4 Testing Cost-Effective for HIV Patients in Areas Lacking Access to Secone-Line ARV Treatments
• Immunization (U.S.) - BD, among the world's leading manufacturers of injection products, is a global partner in worldwide immunization efforts... »